ARK Investment Management 13F: Adds $44M to GeneDx (WGS) Stake

ARK Investment Management recently reported a significant increase in its holdings of WGS. According to its latest 13F filing with the SEC, ARK added 720,022 shares, boosting its total to 1,324,583 shares. This change represents an increase of 119%, with the position valued at approximately $81.2 million as of the reporting period.

What Changed in ARK Investment Management's WGS Position

ARK Investment Management's decision to boost its stake in WGS involved adding 720,022 shares to its portfolio. Previously holding 604,561 shares, the fund now owns 1,324,583 shares. This substantial increase reflects a 119% jump in their investment in the company.

Other Institutional Activity in WGS

Other institutional investors also made notable changes to their WGS holdings. Corvex Management LP increased its position by 169,520 shares, bringing its total to 3,228,149 shares valued at $207.3 million. Casdin Capital, LLC maintained its holdings steady at 3,007,164 shares, worth about $193.1 million. Meanwhile, BlackRock, Inc. slightly trimmed its position by 9,386 shares, ending with 1,550,708 shares valued at $99.6 million. Westfield Capital Management Co LP significantly increased its stake by 350,847 shares to 1,369,108 shares, valued at $87.9 million. Goldman Sachs Group Inc also added 114,478 shares, bringing its total to 1,334,980 shares, valued at $85.7 million.

GeneDx Holdings Corp. Stock Down 39.3%

Shares of WGS traded around $61.32 recently. The stock has seen varied analyst activity, with multiple firms maintaining buy ratings and setting price targets ranging from $70 to $170.

Insider Buying and Selling at GeneDx Holdings Corp.

Recent insider transactions at WGS included both purchases and sales. On June 9, 2026, Katherine Stueland, the CEO, bought 6,546 shares and sold 6,546 shares. Kevin Feeley, the CFO, purchased 2,462 shares and sold 1,266 shares at an average price of $53.77 per share.

Analysts Set New Price Targets

Several analysts have maintained buy ratings for WGS. On May 5, 2026, Canaccord Genuity and Wells Fargo both kept their buy ratings with a $75 price target. Guggenheim also maintained a buy rating with a $70 target, while BTIG set a target of $90. Earlier, Canaccord had a $100 target on April 20, and Guggenheim matched this on March 30. Piper Sandler and BTIG set higher targets of $130 and $170, respectively, on February 24.

About WGS

WGS operates in the [sector/industry information not provided]. It is headquartered in [location not provided] and led by CEO [CEO name not provided]. The company [description not provided].

Bottom Line

ARK Investment Management's significant increase in WGS shares shows a strong interest in the company as reflected in the substantial 13F filing change. Investors often watch such moves to gauge fund sentiment, though these filings are backward-looking and may not indicate current positions. WGS's stock remains active among institutional investors and analysts, with ongoing interest reflected in insider transactions and analyst ratings.